This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 5, No 1 (2016): Jan-Mar

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Authors of this article:

Stefan Viktor Vormfelde1 Author Orcid Image ;   Sonja Ortler1 Author Orcid Image ;   Tjalf Ziemssen2 Author Orcid Image
Article Authors Cited by (10) Tweetations (4) Metrics

Stefan Viktor Vormfelde   1 , MD,PhD ;   Sonja Ortler   1 , PhD ;   Tjalf Ziemssen   2 , MD,PhD

1 Novartis Pharma GmbH, Clinical Research in Neuroscience, Nuremberg, Germany

2 Klinik und Poliklinik für Neurologie, Zentrum für klinische Neurowissenschaften, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

Corresponding Author:

  • Tjalf Ziemssen, MD,PhD
  • Klinik und Poliklinik für Neurologie
  • Zentrum für klinische Neurowissenschaften
  • Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
  • Fetscherstr. 43
  • Dresden
  • Germany
  • Phone: 49 351-4584465
  • Fax: 49 351-4585717
  • Email: Tjalf.Ziemssen@uniklinikum-dresden.de